Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1002670 (Vilaprisan)
Clinical trial NCT03092999 · COMPLETED
Trial details
- NCT number
- NCT03092999
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-28
- Primary completion
- 2017-07-17
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.